GlaxoSmithKline Consumer Healthcare, Inc.
GlaxoSmithKline Consumer Healthcare, Inc. (GSK Consumer Healthcare) is a leading player in the global consumer health industry, headquartered in California. Founded in 2019, following the merger of GlaxoSmithKline's consumer health division with Pfizer's consumer healthcare business, the company has rapidly established itself in key operational regions, including North America, Europe, and Asia.
GSK Consumer Healthcare focuses on a diverse range of products, including oral health, pain relief, respiratory health, and dietary supplements. Its portfolio features well-known brands such as Sensodyne, Panadol, and Voltaren, which are distinguished by their commitment to scientific innovation and consumer trust. With a strong market position, GSK Consumer Healthcare continues to achieve notable milestones, reinforcing its reputation as a leader in the consumer healthcare sector.
+47 vs industry average
GlaxoSmithKline Consumer Healthcare, Inc.’s score of 87 is higher than 95% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at GlaxoSmithKline Consumer Healthcare, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for GlaxoSmithKline Consumer Healthcare, Inc. yet.
GlaxoSmithKline Consumer Healthcare, Inc.'s reported carbon emissions
GlaxoSmithKline Consumer Healthcare, Inc., headquartered in California, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of GSK plc, which means that any climate commitments or emissions data may be inherited from its parent organisation.
GSK plc has set ambitious climate targets, which include commitments to reduce greenhouse gas emissions across its operations. These initiatives are part of a broader strategy to achieve net-zero emissions by 2030 for its own operations (Scope 1 and 2) and by 2045 for its value chain (Scope 3). The company is actively engaged in various sustainability initiatives, including participation in the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative, which focuses on 100% renewable energy.
While specific emissions figures for GlaxoSmithKline Consumer Healthcare, Inc. are not available, the overarching climate commitments from GSK plc indicate a strong focus on reducing carbon footprints and enhancing sustainability practices across its corporate family.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
GlaxoSmithKline Consumer Healthcare, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for GlaxoSmithKline Consumer Healthcare, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Haleon plc
Carbon Disclosure Project
Inherited from Haleon plcThe Climate Pledge
Inherited from Haleon plcUN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsNo peer comparison is available for GlaxoSmithKline Consumer Healthcare, Inc. yet.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project